Ibrutinib CAS 936563-96-1 | Inhibitor | Supplier

Ibrutinib

CAS 1642-81-5 | Ibrutinib

CAS No:936563-96-1
Formula:C25H24N6O2
EINECS:805-642-2
Stock Availability:In stock
Brand Name:Zhishang New Materials
Origin:China

Product Details of Ibrutinib

Ibrutinib is a Bruton’s tyrosine kinase (BTK) inhibitor at the mechanistic degree. In governing evaluation products and other public information, ibrutinib is called a BTK prevention; its empirical formula, molecular weight, appearance, and normal physicochemical characteristics such as “soluble in DMSO, soluble in methanol, and almost insoluble in water” can likewise be located (various documents might concentrate on various elements, and it is suggested to select the recommendation source according to job needs).
Concerning storage space and preparation, various storage and prep work recommendations can be discovered in product details offered via public channels. For instance, some sources give empirical data on storage at -20 ° C and “solubility in organic solvents such as DMSO, DMF, and ethanol”, while also showing that it is a type that is reasonably difficult to liquify straight in liquid barrier services, requiring an extra mindful preparation approach.
1) BTK lies on a vital cell signaling pathway
BTK belongs to the BTK/Tec family of protein tyrosine kinases and occupies an essential placement in the signaling network associated with B cells. Proving ground around BTK often focuses on immune signal transduction, cell activation, and downstream pathway regulation. Consequently, BTK inhibitors are also generally used in associated system research, target validation, and approach growth.
 
2) Core mechanism of ibrutinib: active website binding + covalent adjustment
Ibrutinib is frequently identified as a “covalent (irreversible)” BTK inhibitor. Literature evaluations and structural system studies generally mention that it creates a covalent bond with the vital cysteine site Cys481 near the ATP binding pocket of BTK; this process is connected to the acrylamide group in the particle and is often called a Michael addition-related reaction path.
 
3) The value of “covalent“: it’s not almost being stronger, but more about “resilience” and greater dependence on top quality consistency
The feature of covalent binding depends on that once an efficient binding is developed, the target enzyme activity will certainly display an extra continual repressive state (till factors such as healthy protein turnover alter the system). For buyers, such particles typically require even more attention: stereochemical uniformity, pollutants related to reactive functional groups, and stability of pollutant profiles in between batches. To put it simply, the “activity attributes” of ibrutinib directly shift the focus of purchasers back to the quality assurance of raw materials.
Benefit 1: The structural info is clear, and stereochemistry can be confirmed with conventional approaches
The systematic naming of ibrutinib in published materials consists of the stereochemical info of (3R) (i.e., it is not a compound with “negligible structural info”). This is necessary for procurement: it suggests that you can use a lot more direct analytical approaches (such as chiral connection methods, NMR essential site analysis, LC-MS architectural verification, etc) to confirm “whether what you buy is what you want”. Extra full naming and architectural info can be found in different published materials, yet various files may embrace different calling systems; it is recommended to make use of CAS + architectural formula/SMILES/InChIKey as cross-checking areas in procurement documents to assist in cross-team interaction and record archiving.
 
Benefit 2: The clear correlation in between solubility and pH is beneficial for you to create even more secure solution and approach techniques
Reduced solubility in water is an often stated quality of ibrutinib; on the other hand, its solubility is substantially related to pH: public data indicates a pKa of approximately 3.7– 4.0, and gives instance solubility information (e.g., the solubility can get to roughly 1.6 mg/mL at pH 1, while it can be as reduced as approximately 0.003 mg/mL at pH 4.5 and pH 8 in particular barrier systems; certain worths are related to check tool, ionic toughness, and other problems). This type of “measurable solubility variant” is of great referral value for method growth, impurity detection, and example pretreatment.
 
Benefit 3: Reference to storage and security information is readily available, which is helpful for organizing lasting jobs
Some item details products provide more “useful” storage space suggestions (such as -20 ° C )and security descriptions, but such summaries are frequently pertaining to product packaging systems, moisture and light control strategies, example forms (powder/solution), and other problems. In even more standardized top quality systems, security and management needs are also frequently shared in terms of retest periods/shelf lives. For buyers, such information can aid you prepare beforehand: sample retention, setup of retesting cycles, aliquoting methods, and cost evaluation of temperature level control schemes for international transportation. It needs to be kept in mind that variants in packaging systems, wetness control, and set differences amongst various vendors can cause fluctuations in “real performance upon arrival”, so stability is best taken care of with closed-loop monitoring with set CoA, essential arrival retesting, and example retention observation.

A: The product we offer corresponds to CAS 936563-96-1, with a molecular formula of C ₂₅ H ₂₄ N ₆ O two and a molecular weight of 440.50. This info will be consistent in papers such as CoA/labels/packing lists, to avoid the circumstance of “very same material with different names” in inner warehousing systems and regulative papers.

A: Public details exposes that its mainstream supply forms are mainly defined in the form of cost-free bodies, and there are instances of solid-state type monitoring such as crystal/polymorph administration; on the other hand, salt forms, solvates, or other solid-state kinds might also appear in r & d and supply chains. We advise clearly including “type definition + verification approach” in the procurement specifications and applying it in the release examination. We will certainly use NMR, LC-MS, and various other techniques to validate the framework; if it is needed to distinguish between complimentary bodies and salt forms, it is normally required to incorporate counter-ion-related discovery (such as ion chromatography or various other relevant counter-ion quantification/identification techniques); if it is needed to recognize a specific crystal/polymorph, it is generally necessary to make use of XRPD and can be incorporated with solid-state characterization methods such as DSC/TGA to develop a determination requirement.

A: The systematic naming of ibrutinib consists of (3R) stereochemical details. We generally offer structure confirmation information (such as NMR/LC-MS). If the consumer requires even more stereochemical confirmation, chiral approaches can be added or third-party screening can be contracted out according to job requirements, and the outcomes can be included in the set documents.

A: For purchase, “a solitary total purity number” is frequently not enough. A more stable method is to break down the indications:
 
Assay (Web Content): HPLC, and so on (Based on the approach accepted by your top quality system).
Relevant materials: Limit and reporting threshold for specific impurity/total pollutant.
Residual solvents, wetness, and essential pollutants: Set according to project and destination demands.
We recommend that you request the provider to offer a “approach summary + regular chromatogram” throughout the questions stage, as this will facilitate the assessment of batch consistency and risk points.

A: The solubility of ibrutinib in water is relatively low, which is a constant summary in public info; at the same time, its solubility is dramatically related to pH (pKa is about 3.7– 4.0, and there are published information on solubility distinctions at different pH levels). In practice, a more typical technique is to initial prepare a stock remedy making use of natural solvents such as DMSO, and after that dilute it to the target system as needed. If you are conducting approach recognition, it is recommended to consist of “solvent system/dilution sequence/ultrasonic and temperature level control conditions” in the SOP to lower human irregularity.

A: There are recommendations for storage space at -20 ° C given in the documentation; in more standardized top quality systems, needs for security monitoring are commonly defined in terms of retesting periods/shelf life. Whether cold chain is required for transportation normally relies on: period, duration of the course, personalizeds clearance uncertainties, and your approach for retesting upon arrival. Our favored strategy is to give packaging and temperature level control options (such as shielded boxes with cooling agent, temperature level recording, and so on) based on the destination climate and transportation period, and plainly specify the suggestions in the documentation.

A: Routine distribution documents generally consist of:
 
CoA (Certificate of Evaluation): Assay/Related substances/Moisture/Residual solvents, and so on (According to customer specifications).
SDS: made use of for transport and EHS analysis.
Architectural confirmation data: generally consisting of NMR and LC-MS (given by batch or by project).
Methodological information: HPLC conditions, system viability recommendations, etc.
If you call for third-party evaluation, original information bundles, or a more detailed list of high quality records, it is additionally recommended to list them throughout the RFQ (Request for Quote) phase, to ensure that the workload and timeline can be clearly approximated when providing a quotation.

A: Yes, the secret is the “consistency method”: we generally recommend that examples come from the same procedure path and high quality standard as the planned supply, and carry out set retention and crucial indication contrast (such as relevant compound range, web content, moisture/residual solvent window, etc) throughout subsequent scaled-up supply, to minimize the danger of “samples work well yet bulk goods vary”.

A: Different tasks have dramatically varying requirements for data depth. Common areas of collaboration consist of:.
 
Recap of bottom lines from set records, and summary of important process control factors (based on confidentiality boundaries).
Analysis of impurity sources and control approaches (including summaries of possible process-related impurities).
Change alert mechanism (interaction cycle for adjustments in raw materials, procedures, essential tools, and so on).
If you have a clear location market and information template, it is suggested to clearly state the “information list + shipment time” in the procurement agreement, which will promote the procedure.
A: We recommend specifying the procedure as “executable” as opposed to just writing “take full responsibility”. A typical technique is:
 
Upon arrival, finish the review of appearance, labeling, and essential indications within the agreed duration.
If disparities arise, both celebrations will recognize the cause based upon kept example retesting + third-party testimonial (if essential) **.
For the confirmed bothersome sets, return, replacement, or reshipment will be performed according to the contract agreement, and CAPA (Corrective and Preventive Activity) information shall be integrated.
For customers, this system can reduce the cost of cross-border cooperation more effectively than spoken dedications.